Vanguard Global Advisers
PLSE icon

Vanguard Global Advisers’s Pulse Biosciences PLSE Stock Holding History

Vanguard Global Advisers’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
13,198
+2,339
+22% +$55.2K ﹤0.01% 2250
2026
Q1 		$234K Buy
+10,859
New +$200K ﹤0.01% 2360

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Global Advisers's PLSE Position: Q2 2026 in Review

Vanguard Global Advisers increased its Pulse Biosciences (PLSE) stake by 22% in Q2 2026, buying an estimated $55.2K and bringing the position to 13,198 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

Vanguard Global Advisers first reported a position in PLSE in Q1 2026 and has held it in 2 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Vanguard Global Advisers held 13,198 shares of Pulse Biosciences worth $366K as of Q2 2026.
  • Vanguard Global Advisers bought 2,339 Pulse Biosciences shares in Q2 2026, an estimated $55.2K.
  • Pulse Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2250 holding.
  • Vanguard Global Advisers first reported a position in Pulse Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.